1Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression[J]. Nat Rev Immunol,2005,5(10) :749-759.
2Sarkar FH, Li Y, Wang Z, et al. NF-kappaB signaling pathway and its therapeutic implications in human disea- ses[J]. Int Rev lmmunol, 2008,27 (5) :293-319.
3Naugler WE,Karin M. NF-kappaB and cancer-identifying targets and mechanisms[J]. Curt Opin Genet Dev, 2008, 18(1) : 19-26.
4Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism[J]. Cell, 1986,47(6) : 921-928.
5Tak PP,Firestein GS. NF-κB: a key role in inflammatory diseases[J]. J Clin Invest,2001,107(1) :7-11.
6Hoffmann A, Levchenko A, Scott ML, et al. The IkappaB- NF-kappaB signaling module: temporal control and selec- tive gene activation[J]. Science,2002,298 : 1241-1245.
7Kearns JD, Basak S, Wemer SL, et al. IkappaB epsilon provides negative feedback to control NF-kappaB oscilla- tions, signaling dynamics, and inflammatory gene expres- sion[J]. J Cell Biol, 2006,173 (5) : 659-664.
8Motoyama M, Yamazaki S, Eto-Kimura A, etal. Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein [J]. J Biol Chem,2005,280(9) :7444-7451.
9Lawrence T, Bebien M, Liu'GY, et al. IKKalpha limits macro- phage NF-kappaB activation and contributes to the resolution of inflammation[J]. Nature, 2005,434 : 1138-1143.
10Perkins ND. Integrating cell-signaling pathways with NF- κB and IKK function[J]. Nat Rev Mol Cell Biol,2007,8: 49-62.
5Hassouna I, Wickert H, Zimmermann M, et al. Increase in bax ex- pression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine(MPTP) treatment of mice [ J ]. Neurosci Lett, 1996, 2004: 85-88.
6XuBB, Liu CQ, Gao X, et al. Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model [ J ]. J Asian Nat Prod Res, 2005, 7:215 -224.
7Brown KD, Clandio E, Siebenlist U. The roles of the classical and al- ternative nuclear factor-kb pathways : potential implications for auto- immunity and rheumatoid arthritis [ J ]. Arthritis Res Ther, 2008, 10:212 - 225.
8Arumugam TV, Woodruff TM, Lathia JD, et al. Neuroprotection in stroke by complement inhibition and immunoglobnlin therapy [ J ] . Neuroscience, 2009, 158 : 1074 - 1089.
9Karin M. Nuclear factor-kappaB in cancer development and progres- sion [ J ]. 2006, 441:431 - 436.
10Toruner M, Femandez-Zapici M, Sha JJ, et al. Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprote- gerin, BCL-2, and IAP-1 [ J]. J Biol Chem, 2006, 28 : 8686 - 8689.
